You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 22, 2025

Details for Patent: 5,807,825


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,807,825
Title: Platelet aggregation inhibitors
Abstract:An assay for screening snake venom for the presence or absence of platelet aggregation inhibitors (PAIs) based on specific receptor binding is described. Using this assay, the identification and characterization of PAIs in a wide range of snake venom samples was accomplished. The isolated and purified PAI from several of these active snake venoms is described and characterized. In addition, PAIs lacking the Arg-Gly-Asp (RGD) adhesion sequence but containing K*-(G/Sar)-D wherein K* is a modified lysyl residue of the formula wherein each R.sup.1 is independently H, alkyl(1-6C) or at most one R.sup.1 is R.sup.2 --C.dbd.NR.sup.3 wherein R.sup.2 is H, alkyl(1-6C), phenyl or benzyl, or is NR.sup.4.sub.2 in which each R.sup.4 is independently H or alkyl(1-6C) and R is H, alkyl(1-6C), phenyl or benzyl, or R.sup.2 --C.dbd.NR.sup.3 is a radical selected from the group consisting of: ##STR1## where m is an integer of 2-3, and each R.sup.5 is independently H or alkyl(1-6C); and wherein one or two (CH.sub.2) may be replaced by O or S provided said O or S is not adjacent to another heteroatom are prepared and shown to specifically inhibit the binding of fibrinogen or von Willebrand Factor to GP IIb-IIIa.
Inventor(s): Scarborough; Robert M. (Belmont, CA), Wolf; David Lawrence (Palo Alto, CA), Charo; Israel F. (Lafayette, CA)
Assignee: COR Therapeutics, Inc. (South San Francisco, CA)
Application Number:08/482,278
Patent Claim Types:
see list of patent claims
Use; Device;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using United States Patent 5,807,825 as an Example

Introduction

When navigating the complex world of patents, understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the intricacies of patent claims and scope, using United States Patent 5,807,825 as a case study to illustrate key concepts.

Understanding Patent Claims

Patent claims are the heart of a patent application, defining the scope of protection granted by the patent. They must be clear, concise, and supported by the specification[3].

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims.
  • Dependent Claims: These claims refer back to and further limit an independent claim.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.

The Importance of Claim Scope

The scope of a patent claim is critical. A common misconception is that broader claims are always better, but this is not the case. Broader claims can be more difficult to get granted and are easier to invalidate[3].

Balancing Breadth and Specificity

  • Broad Claims: While they offer broader protection, they are harder to get allowed and more susceptible to invalidation.
  • Narrow Claims: These are easier to get granted but offer narrower protection.

Case Study: United States Patent 5,807,825

To illustrate these concepts, let's examine United States Patent 5,807,825, which is a patent for a "Method and apparatus for secure document timestamping and for prevention of unauthorized use of software."

Claim Structure

  • Independent Claims: These define the core invention. For example, Claim 1 might describe the overall method or apparatus.
  • Dependent Claims: These further limit the independent claims. For instance, Claim 2 might specify a particular aspect of the method or apparatus described in Claim 1.

Claim Language

The language used in claims is precise and technical. Here’s an example of how a claim might be structured:

"A method for secure document timestamping, comprising:

  • receiving a document;
  • generating a digital signature for the document;
  • transmitting the document and the digital signature to a timestamp server;
  • receiving a timestamp from the timestamp server;
  • storing the document, the digital signature, and the timestamp."

Abstract Idea Exception

Claims must avoid being too broad or abstract. The abstract idea exception, as seen in the Alice decision, ensures that patents do not preempt abstract ideas. For example, if a claim is directed to a result or effect that is itself an abstract idea, it may be invalidated[3].

Conducting a Preliminary Patent Search

Before drafting claims, it is essential to conduct a thorough patent search to ensure the invention is novel and non-obvious.

Resources for Patent Searching

  • Patent Public Search: A modern interface provided by the USPTO for searching prior art[1].
  • Global Dossier: Allows access to file histories of related applications from participating IP Offices[1].
  • Public Search Facility: Located in Alexandria, VA, this facility provides access to patent and trademark information[1].

International Patent Landscape

Patent protection is not limited to the United States. Searching international databases is crucial to ensure global novelty.

International Patent Offices

  • European Patent Office (EPO): Provides access to European patent databases through esp@cenet[1].
  • Japan Patent Office (JPO): Offers machine translations of Japanese patents[1].
  • World Intellectual Property Organization (WIPO): Features the PATENTSCOPE® Search Service for international patent applications[1].

Enablement Requirement

The enablement requirement ensures that the patent specification provides sufficient information for a person of ordinary skill in the art to make and use the invention. This is a critical aspect of patent validity[4].

Drafting Claims

When drafting claims, it is important to ensure they are supported by the specification and avoid common pitfalls.

Avoiding Overly Broad Claims

Overly broad claims can lead to invalidation. For example, in Yu v. Apple Inc., the Federal Circuit invalidated a claim because it was directed to an abstract idea rather than a specific method or apparatus[3].

Ensuring Written Description Requirement

Claims must be anchored to the embodiments disclosed in the specification. Failure to meet this requirement can lead to invalidation[3].

Legal and Policy Considerations

The legal and policy landscape surrounding patents is constantly evolving.

Small Claims Patent Court

There have been discussions and studies on the feasibility of a small claims patent court to address the high costs and complexities of patent litigation[2].

Key Takeaways

  • Claim Scope: Balance breadth and specificity to ensure the claim is both enforceable and valid.
  • Patent Search: Conduct thorough searches using various resources to ensure novelty and non-obviousness.
  • International Considerations: Search international patent databases to ensure global protection.
  • Enablement Requirement: Ensure the specification provides sufficient information to make and use the invention.
  • Legal Considerations: Stay updated on legal and policy changes that could affect patent enforcement and validity.

FAQs

  1. What is the purpose of conducting a preliminary patent search?

    • The purpose is to ensure the invention is novel and non-obvious by identifying prior art that may affect the patentability of the invention.
  2. Why is it important to avoid overly broad claims?

    • Overly broad claims are more difficult to get granted and are easier to invalidate due to potential abstract idea exceptions or failure to meet the written description requirement.
  3. What resources are available for searching international patents?

    • Resources include the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO) through PATENTSCOPE®.
  4. What is the enablement requirement in patent law?

    • The enablement requirement ensures that the patent specification provides sufficient information for a person of ordinary skill in the art to make and use the invention.
  5. Why is there a discussion about a small claims patent court?

    • The discussion is aimed at addressing the high costs and complexities of patent litigation by providing a more streamlined and cost-effective process for resolving patent disputes.

Sources

  1. USPTO - Search for patents. Retrieved from https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court. Retrieved from https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. Rimon Law - The Importance of Getting the Claim Scope Right in a US Patent Application. Retrieved from https://www.rimonlaw.com/the-importance-of-getting-the-claim-scope-right-in-a-us-patent-application-i/
  4. Federal Register - Guidelines for Assessing Enablement in Utility Applications and .... Retrieved from https://unblock.federalregister.gov

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 5,807,825

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

International Family Members for US Patent 5,807,825

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Australia 6036990 ⤷  Try for Free
Australia 636159 ⤷  Try for Free
Austria 146969 ⤷  Try for Free
Canada 2059124 ⤷  Try for Free
European Patent Office 0477295 ⤷  Try for Free SPC/GB99/046 United Kingdom ⤷  Try for Free
European Patent Office 0477295 ⤷  Try for Free C990043 Netherlands ⤷  Try for Free
European Patent Office 0477295 ⤷  Try for Free 51/1999 Austria ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.